Estate Counselors, LLC Atea Pharmaceuticals, Inc. Transaction History

Estate Counselors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$5.49 - $8.79 $10,980 - $17,580	-2,000 Reduced 66.67%	1,000 $5,000
Q1 2022 May 09, 2022	BUY	$5.5 - $9.19 $16,500 - $27,570	3,000 New	3,000 $21,000
Q4 2021 Feb 14, 2022	SELL	$7.67 - $44.59 $3,835 - $22,295	-500 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$21.33 - $35.06 $10,665 - $17,530	500 New	500 $17,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $270M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Estate Counselors, LLC, based on Form 13F filings with the SEC.

Stay updated on Estate Counselors, LLC with notifications on news.